Peetz Christopher
CHIEF EXECUTIVE OFFICER, Director
1 filing on record here, covering MIRM. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
| Exercise | MIRM | Mirum Pharmaceuticals, Inc. | $58,720 |
| Sell | MIRM | Mirum Pharmaceuticals, Inc. | $1,150,892 |
| Sell | MIRM | Mirum Pharmaceuticals, Inc. | $597,187 |
| Sell | MIRM | Mirum Pharmaceuticals, Inc. | $230,322 |
| Exercise | MIRM | Mirum Pharmaceuticals, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.